Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00415558 · ClinicalTrials.gov registry record · NA
Prospective Clinical Study of the Guidant Microwave Ablation System for the Treatment of PAF in the MIS Procedure
A NA study, sponsored by Maquet Cardiovascular.
- Terminated
- Registry status
- NA
- Development phase
NCT00415558: Clinical Trial NA study, sponsored by Maquet Cardiovascular.
NCT00415558 is a NA study that was terminated before completion, run by Maquet Cardiovascular. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00415558, a NA study, was terminated before completion, sponsored by Maquet Cardiovascular.
- TERMINATED
- Registry status
- NA
- Development phase
Study Summary
The purpose of this prospective, single-arm, un-blinded, multi-site clinical study is to assess the safety and efficacy of the Microwave Ablation System for the treatment of symptomatic paroxysmal atrial fibrillation (PAF) in the minimally invasive surgical (MIS) procedure in approximately 30 patients at 6 investigational sites in the United States.
Interventions
- DEVICE Microwave Ablation System
Trial Details
| Field | Value |
|---|---|
| Start Date | 2007-05 |
| Phase | NA |
Why NCT00415558 stopped before completion
NCT00415558 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Microwave Ablation System is the first listed.
NCT00415558 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00415558 about?
NCT00415558 is a clinical study titled "Prospective Clinical Study of the Guidant Microwave Ablation System for the Treatment of PAF in the MIS Procedure". The purpose of this prospective, single-arm, un-blinded, multi-site clinical study is to assess the safety and efficacy of the Microwave Ablation System for the treatment of symptomatic paroxysmal atrial fibrillation (PAF) in the minimally invasive surgical (MIS) procedure in approximately 30 patien...
What is the current status of trial NCT00415558?
This trial is currently terminated. It is a NA study. The study started on 2007-05.
What interventions are being tested in trial NCT00415558?
The interventions under investigation include: Microwave Ablation System (DEVICE).
Who is sponsoring clinical trial NCT00415558?
This trial is sponsored by Maquet Cardiovascular, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia